CONVELO
Live / Applied — Fourth extension granted (statement of use) (as of 18 Nov 2025)
What this means for you
Not registered yet, but its 22 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97323699
- Mark type
- Stylized text
- Filed
- 22 Mar 2022
- Published for opposition
- 07 Nov 2023
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of multiple sclerosis, genetic leukodystrophies, Alzheimer's disease, cerebral palsy, neurological diseases, disorders, and conditions, central nervous system diseases, disorders, and conditions, brain diseases, disorders, and conditions, age-related diseases, disorders, and conditions, diseases, disorders, and conditions related to myelin loss
- Class 042 — Scientific and technological services: Pharmaceutical research and development services
Owner
- Convelo Therapeutics, Inc., Cleveland, OH, US
- Convelo Therapeutics, Inc., Cleveland, OH, US
Prosecution history
- 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2025 — SOU EXTENSION 4 GRANTED
- 18 Nov 2025 — SOU EXTENSION 4 FILED
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jun 2025 — SOU EXTENSION 3 GRANTED
- 26 Jun 2025 — SOU EXTENSION 3 FILED
- 26 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jan 2025 — SOU EXTENSION 2 GRANTED
- 02 Jan 2025 — SOU EXTENSION 2 FILED
- 02 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2024 — SOU EXTENSION 1 GRANTED
- 02 Jul 2024 — SOU EXTENSION 1 FILED